Healthcare
Oct 2024
October 17, 2024 A new vaccine offers hope for treating and preventing the infectious and difficult-to-treat infection with Clostridium difficile, also known as C. difficile or C. diff. In animal models, this is the first C. difficile mRNA-LNP vaccine that protects against C . According to the researchers, it improves primary and new infections by stimulating a strong immune response, eliminating C. diff bacteria from the gut, and even overcoming the weakness of the host. to care for animals after death. The results pave the way for clinical studies of this vaccine.
Scientists have discovered a new process in our immune systems that leads to the production of an important family of anti-viral proteins called interferons. They hope the discovery will now lead to new, effective therapies for people with some autoimmune and infectious diseases. Researchers have found that a natural metabolite called Itaconate can stimulate immune cells to make interferons by blocking an enzyme called SDH.
Read more…